» Articles » PMID: 38066518

Epidemiological Features of SARS-CoV-2 Omicron Infection Under New Control Strategy: a Cross-sectional Study of the Outbreak Since December 2022 in Sichuan, China

Overview
Publisher Biomed Central
Specialty Public Health
Date 2023 Dec 9
PMID 38066518
Authors
Affiliations
Soon will be listed here.
Abstract

Background: A major shift in the "dynamic zero-COVID" policy was announced by China's National Health Commission on December 7, 2022, and the subsequent immediate large-scale outbreak of SARS-CoV-2 infections in the entire country has caused worldwide concern. This observational cross-sectional study aimed to describe the epidemiological characteristics of this outbreak in Sichuan, China.

Methods: All data were self-reported online by volunteers. We described the epidemic by characterizing the infection, symptoms, clinical duration, severity, spatiotemporal clustering, and dynamic features of the disease. Prevalence ratio (PR), Odds ratios (ORs) and adjusted ORs were calculated to analyze the associations between risk factors and infection and the associations of risk factors with clinical severity using log-binomial and multivariable logistic regression models; 95% confidence intervals (CIs) and Wald test results were reported. The prevalence rates and clinical severity among different subgroups were compared using the Chi-square and trend Chi-square tests.

Results: Between January 6 and 12, 2023, 138,073 volunteers were enrolled in this survey, and 102,645 were infected with COVID-19, holding a prevalence rate of 74.34%; the proportion of asymptomatic infections was 1.58%. Log-binomial regression revealed that the risk of infection increased among those living in urban areas. Multivariable logistic regression analysis showed that female sex, chronic diseases, older age and the fewer doses of vaccine received were associated with an increased risk of severe clinical outcomes after infection. We estimated the mean reproduction number during this pandemic was 1.83. The highest time-dependent reproduction number was 4.15; this number decreased below 1 after 11 days from December 7, 2022. Temporal trends revealed a single peak curve with a plateau pattern of incidence during the outbreak, whereas spatiotemporal clustering analysis showed that the onset in 21 cities in the Sichuan province had four-wave peaks.

Conclusions: The peak of the first wave of Omicron infection in Sichuan Province had passed and could be considered a snapshot of China under the new control strategy. There were significant increases in the risk of severe clinical outcomes after infection among females, with chronic diseases, and the elderly. The vaccines have been effective in reducing poor clinical outcomes.

Citing Articles

Difference of SARS-CoV-2 infection and influence factors between people with and without HIV infection.

Yang J, Strodl E, Zhang D, Jiang H, Chu K, Tan S BMC Public Health. 2025; 25(1):386.

PMID: 39885441 PMC: 11783751. DOI: 10.1186/s12889-025-21400-8.


The Incidence and Clinical Characteristics of COVID-19 in Children With IBD During the Omicron Wave: A Single-Center Experience in China.

Li R, Chen P, Li H, Ren L, Cheng Y, Liu L Gastroenterol Res Pract. 2025; 2025:1868214.

PMID: 39850808 PMC: 11756934. DOI: 10.1155/grp/1868214.


Estimating cumulative infection rate of COVID-19 after adjusting the dynamic zero-COVID policy in China.

Zhou S, Lai M, Tang S, Liu W, Shen M, Peng Z Infect Dis Model. 2025; 10(2):429-438.

PMID: 39816753 PMC: 11732547. DOI: 10.1016/j.idm.2024.12.012.


Work stress and professional quality of life among Chinese nurses during the COVID-19 pandemic: the chain mediating role of self-compassion and benefit finding.

Hui Z, Wang C, Sun J, Han W, Wang T, Li J BMC Public Health. 2024; 24(1):2830.

PMID: 39407180 PMC: 11475858. DOI: 10.1186/s12889-024-20293-3.


JN.1: enhanced immune evasion ability propels it to become the predominant strain in China, unlikely to trigger pandemic similar to late 2022.

Du P, Li M, Wei G, Guo C, Li N Front Public Health. 2024; 12:1442291.

PMID: 39391153 PMC: 11464334. DOI: 10.3389/fpubh.2024.1442291.


References
1.
Lau J, Cheng S, Leung K, Lee C, Hachim A, Tsang L . Real-world COVID-19 vaccine effectiveness against the Omicron BA.2 variant in a SARS-CoV-2 infection-naive population. Nat Med. 2023; 29(2):348-357. PMC: 9941049. DOI: 10.1038/s41591-023-02219-5. View

2.
Simons D, Shahab L, Brown J, Perski O . The association of smoking status with SARS-CoV-2 infection, hospitalization and mortality from COVID-19: a living rapid evidence review with Bayesian meta-analyses (version 7). Addiction. 2020; 116(6):1319-1368. PMC: 7590402. DOI: 10.1111/add.15276. View

3.
Kim D, Ali S, Kim S, Jo J, Lim J, Lee S . Estimation of Serial Interval and Reproduction Number to Quantify the Transmissibility of SARS-CoV-2 Omicron Variant in South Korea. Viruses. 2022; 14(3). PMC: 8948735. DOI: 10.3390/v14030533. View

4.
Erikstrup C, Laksafoss A, Gladov J, Kaspersen K, Mikkelsen S, Hindhede L . Seroprevalence and infection fatality rate of the SARS-CoV-2 Omicron variant in Denmark: A nationwide serosurveillance study. Lancet Reg Health Eur. 2022; 21:100479. PMC: 9355516. DOI: 10.1016/j.lanepe.2022.100479. View

5.
Leung K, Lau E, Wong C, Leung G, Wu J . Estimating the transmission dynamics of SARS-CoV-2 Omicron BF.7 in Beijing after adjustment of the zero-COVID policy in November-December 2022. Nat Med. 2023; 29(3):579-582. DOI: 10.1038/s41591-023-02212-y. View